Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Nov;27(4):1003-1013.
doi: 10.1016/j.ncl.2009.06.001.

Identification of pharmacoresistant epilepsy

Affiliations
Review

Identification of pharmacoresistant epilepsy

Anne T Berg. Neurol Clin. 2009 Nov.

Abstract

There is no single definition of pharmacoresistant (intractable, refractory) epilepsy. Prospective identification of pharmacoresistance is complicated by the variability of its appearance across different types of epilepsy and the variability of seizure control within a given patient over time. Failure of informative trials of two appropriate antiepileptic drugs has been recommended as a threshold that should trigger referral for evaluation at a comprehensive epilepsy center. Maximizing seizure control is imperative for reducing the risks and consequences of epilepsy, including the cognitive and psychiatric comorbidities and even sudden death.

PubMed Disclaimer

References

    1. Arts WFM, Brouwer OF, Peters ACB, et al. Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain. 2004;127:1774. - PubMed
    1. Arzimanoglou A, Ryvlin P. Toward a clinically meaningful definition of drug resistance. In: Kahane P, Berg A, Loscher W, et al., editors. Drug Resistant Epilepsy. Montrouge: John Libbey Eurotext; 2008. p. 1.
    1. Bell GS, Gaitatzis A, Bell CL, et al. Drowning in people with epilepsy: How great is the risk? Neurology. 2008;71:578. - PubMed
    1. Berg AT. Introduction to the epilepsies. In: Engel JPT, editor. Epilepsy: A Comprehensive Text. 2. Philadelphia: Lippincott-Raven Press; 2008. p. 761.
    1. Berg AT. The risks, correlates, and temporal patterns of intractable epilepsy. In: Kahane P, Berg A, Loscher W, et al., editors. Drug resistant epilepsies. Montrouge, France: John Libbey Eurotext; 2008. p. 7.

Publication types

Substances